Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Gross Margin (2019 - 2025)

Silo Pharma (SILO) has disclosed Gross Margin for 7 consecutive years, with 14.77% as the latest value for Q4 2025.

  • Quarterly Gross Margin fell 10667.0% to 14.77% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 38.57% through Dec 2025, down 5334.0% year-over-year, with the annual reading at 38.57% for FY2025, 5334.0% down from the prior year.
  • Gross Margin hit 14.77% in Q4 2025 for Silo Pharma, roughly flat from 14.77% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 91.91% in Q2 2022 to a low of 10101.22% in Q4 2021.
  • Historically, Gross Margin has averaged 614.37% across 5 years, with a median of 91.9% in 2022.
  • Biggest five-year swings in Gross Margin: plummeted -954477bps in 2021 and later soared 1019312bps in 2022.
  • Year by year, Gross Margin stood at 10101.22% in 2021, then surged by 101bps to 91.9% in 2022, then changed by 0bps to 91.9% in 2023, then changed by 0bps to 91.9% in 2024, then crashed by -116bps to 14.77% in 2025.
  • Business Quant data shows Gross Margin for SILO at 14.77% in Q4 2025, 14.77% in Q3 2025, and 91.91% in Q2 2025.